Study on Reduced Radiation and Chemotherapy for HPV-Positive Throat Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
ClinicalTrials ID:NCT06984861
This clinical trial is exploring whether using lower doses of radiation therapy, along with standard chemotherapy, is as effective as the usual higher doses for treating HPV-positive throat cancer. The chemotherapy drugs used in this study include cisplatin, carboplatin, and 5-fluorouracil (5-FU).
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The aim of this study is to find out if using lower doses of radiation therapy, combined with standard chemotherapy, can effectively treat HPV-positive throat cancer. Researchers want to see if this approach works as well as the traditional higher doses of radiation. The chemotherapy drugs involved are cisplatin, carboplatin, and 5-fluorouracil (5-FU).
Eligibility Criteria
Inclusion Criteria
- Diagnosed with HPV-positive squamous cell carcinoma of the throat (including tonsils, base of tongue, or throat walls) confirmed by biopsy.
- Cancer must be visible on scans or physically measurable at the primary site or lymph nodes.
- No evidence of cancer spread to distant parts of the body.
- Must have a CT or MRI scan of the neck.
- General health status should be good, with a performance score of 0-2 or a KPS score of 70 or higher.
- Must be 18 years or older.
- Adequate blood cell counts and organ function based on recent tests.
- Women of childbearing potential must have a negative pregnancy test before joining the study.
- Must be able to undergo MRI scans unless medically exempted.
- Must provide informed consent to participate in the study.
Exclusion Criteria
- Previous radiation therapy to the head and neck area.
- Having another primary cancer outside the throat unless approved by the study investigators.
- History of another invasive cancer unless disease-free for 3 years or with a high cure rate.
- Previous chemotherapy for the throat cancer being studied (chemotherapy for other cancers is allowed).
- Severe health conditions such as recent heart problems, active infections requiring IV antibiotics, or severe lung disease requiring hospitalization.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | 07920 | Basking Ridge | New Jersey |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | 07748 | Middletown | New Jersey |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | 07645 | Montvale | New Jersey |
| Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) | 11725 | Commack | New York |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | 10604 | Harrison | New York |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | 10065 | New York | New York |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | 11553 | Uniondale | New York |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.
